InMed Pharmaceuticals Inc.
Specialising in cannabinoid-based therapies, InMed Pharmaceuticals is a biopharmaceutical company that focuses on conditions resistant to traditional practices. The company is also developing a biosynthesis process so it can replicate cannabinoids without the need to grow cannabis plants. Based in Vancouver, Canada, they have access to an extensive database of cannabinoid drug information.
Specialising in cannabinoid-based therapies, InMed Pharmaceuticals is a biopharmaceutical company that focuses on conditions resistant to traditional practices. The company is also developing a biosynthesis process so it can replicate cannabinoids without the need to grow cannabis plants. Based in Vancouver, Canada, they have access to an extensive database of cannabinoid drug information.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
IN |
$225,110
|
43.11% |
$0.2679
|
| IMLFF |
Total volume
$297,076
|
56.89% |
Stock price
$0.2700
|
